Professor Chris Jackson

Professor Christopher (CJ) Jackson, MBChB, FRACP, MInstD Professor of Oncology, University of Otago; Co-lead, Cancer National Clinical Network, Te Whatu Ora – Health New Zealand; Medical Oncologist, Dunedin Hospital & Mercy Cancer Care; Deputy Dean, Dunedin School of Medicine.

Professor Jackson is a medical oncologist, academic, and health system leader committed to improving access, equity, quality, and outcomes in cancer care. Based in Ōtepoti Dunedin, New Zealand, he specialises in gastrointestinal cancers and melanoma, combining an active clinical practice with leadership roles in health policy, research, and education.

He is Co-Lead of the Cancer National Clinical Network for Te Whatu Ora – Health New Zealand, where he leads national projects to improve systemic anticancer therapy (SACT) access, consistency and outcomes, improving access to medicines, service organisation and quality, improving waiting times for treatment, and introducing new models of cancer care. 

From 2015 to 2021, he served as Medical Director of the Cancer Society of New Zealand, where his advocacy contributed to the development of the New Zealand Cancer Action Plan and the establishment of Te Aho o Te Kahu. 

Internationally, Professor Jackson is a board member of the Union for International Cancer Control (UICC), a member of the Programme Board of the International Cancer Benchmarking Partnership (ICBP), a founding leader of the Common Sense Oncology movement, and an active member of ASCO, ESMO, and the Australasian Gastro-Intestinal Trials Group. He has previously served on ASCO’s Asia-Pacific Regional Council and is currently on the Editorial Board of the Journal of Global Oncology. 

His research interests include health systems and health policy, drug development and clinical trials, collaborative translational research, and the monitoring of cancer care quality. He works extensively with government agencies, cancer charities, research organisations, and clinical networks to achieve evidence-based improvements in patient care. 

In his spare time, he is a committed Radiohead fan, and his children—when pressed—have been known to describe him as “amongst their favourite parents.”

​

Professor Christopher (CJ) Jackson MB ChB FRACP MInstD

Ahorangi Mate Pukupuku | Professor of Oncology, University of Otago

Co-lead, Cancer National Clinical Network, Te Whatu Ora – Health NZ

Medical Oncologist, Southern Blood and Cancer 

Deputy Dean, Dunedin School of Medicine, University of Otago

waea pūkoro: +64 27 284 6810 | īmēra: christopher.jackson@southerndhb.govt.nz

201 Great King St, Dunedin 9016